You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: February 28, 2021

DrugPatentWatch Database Preview

Meclizine hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for meclizine hydrochloride and what is the scope of freedom to operate?

Meclizine hydrochloride is the generic ingredient in two branded drugs marketed by Casper Pharma Llc, Ivax Sub Teva Pharms, Nexgen Pharma Inc, Pliva, Abc Holding, Amneal Pharms, Anabolic, Ani Pharms Inc, Annora Pharma, Bundy, Epic Pharma Llc, Indicus Pharma, Invatech, Jubilant Cadista, Kv Pharm, Mylan Pharms Inc, Par Pharm, Rising, Sandoz, Superpharm, UDL, Vangard, Watson Labs, and Zydus, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for meclizine hydrochloride. Thirty-one suppliers are listed for this compound.

Recent Clinical Trials for meclizine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Mansoura UniversityPhase 1/Phase 2
Hospital Federal de BonsucessoPhase 4
Yvonne SadaPhase 1

See all meclizine hydrochloride clinical trials

Pharmacology for meclizine hydrochloride
Drug ClassAntiemetic
Physiological EffectEmesis Suppression
Medical Subject Heading (MeSH) Categories for meclizine hydrochloride

US Patents and Regulatory Information for meclizine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vangard MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 087620-001 Jan 4, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Anabolic MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET;ORAL 085891-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET;ORAL 010721-004 Approved Prior to Jan 1, 1982 AA RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.